Tuberculosis (TB) in humans is caused by Mycobacterium tuberculosis (Mtb). It is estimated
that 70 million children (< 15 years) are currently infected with Mtb, with 1.2 million each year …

Introduction As studies of biomarkers of tuberculosis (TB) disease provide hope for a simple,
point-of-care test, we aimed to synthesize evidence on biomarkers for diagnosis of TB in …

Background Mycobacterium tuberculosis infection is known to cause inflammation and lung
tissue damage in high-risk populations. Nevertheless, direct associations between …

The diagnosis of pediatric tuberculosis (TB) poses a challenge for clinical teams worldwide.
TB-mediated changes in the expression of host genes in the peripheral blood can serve as …

Pediatric tuberculosis (TB) is challenging to diagnose, confirmed by growth of
Mycobacterium tuberculosis at best in 40% of cases. The WHO has assigned high priority to …

Tuberculosis (TB) is a major public health concern for all ages. However, the disease
presents a larger challenge in pediatric populations, partially owing to the lack of reliable …

INTRODUCTION: The lack of highly-productive Nyssorhynchus darlingi laboratory colonies
limits some studies. We report the first well-established laboratory colony of Ny. darlingi in …

To achieve the ambitious targets for tuberculosis (TB) prevention, care, and control stated by
the End TB Strategy, new health care strategies, diagnostic tools are warranted. Host …

Annually, approximately 10 million people are diagnosed with active tuberculosis (TB), and
1.4 million die of the disease. If left untreated, each person with active TB will infect 10–15 …

Tuberculosis (TB) is a global health concern. Treatment is prolonged, and patients on anti-
TB therapy (ATT) often experience treatment failure for various reasons. There is an urgent …